IRIDEX Corporation (IRIX)

NASDAQ: IRIX · IEX Real-Time Price · USD
3.020
+0.070 (2.37%)
Mar 28, 2024, 3:50 PM EDT - Market closed

Company Description

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.

The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders.

It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures.

The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics.

It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally.

The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995.

IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIDEX Corporation
IRIDEX logo
Country United States
Founded 1989
IPO Date Feb 15, 1996
Industry Medical Devices
Sector Healthcare
Employees 130
CEO David I. Bruce

Contact Details

Address:
1212 Terra Bella Ave
Mountain View, California 94043
United States
Phone (650) 940-4700
Website iridex.com

Stock Details

Ticker Symbol IRIX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001006045
CUSIP Number 462684101
ISIN Number US4626841013
Employer ID 77-0210467
SIC Code 3845

Key Executives

Name Position
David I. Bruce President, Chief Executive Officer and Director
Fuad Ahmad Interim Chief Financial Officer
Patrick Mercer Chief Operating Officer
Leigh Salvo Head of Investor Relations

Latest SEC Filings

Date Type Title
Mar 26, 2024 8-K Current Report
Nov 28, 2023 8-K Current Report
Nov 20, 2023 10-Q Quarterly Report
Nov 14, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Nov 14, 2023 8-K Current Report
Nov 7, 2023 8-K Current Report
Nov 1, 2023 8-K Current Report
Oct 18, 2023 8-K Current Report
Aug 10, 2023 10-Q Quarterly Report
Aug 10, 2023 8-K Current Report